Siab -Purity Baricitinib API Powder rau Immunomodulatory Applications

Feb 05, 2026

Tso lus

Taw qhia

 

 

Nyob rau hauv lub evolving toj roob hauv pes ntawm precision tshuaj,Baricitinib CAS: 1187594-09-7tau tshwm sim raws li lub hauv paus molecule rau kev kho mob autoimmune phenotypes. Raws li tus tswv lag luam B2B,Xi'an Tihealth Biotechnology Co., Ltd.lees paub tias txoj kev vam meej ntawm kev kho mob cuam tshuam yog nyob ntawm tus qauv kev ncaj ncees thiab tshuaj lom neeg sib xws ntawm API. Qhov kev tshuaj ntsuam no txav dhau qhov kev siv tshuaj kho mob los tshawb txog cov ntsiab lus tseem ceeb ntawm kev sib txuas lus thiab kev kho mob tseem ceeb uas txhais tau tias Baricitinib tus nqi lag luam.

Kev pom zoo: Tswj txheej txheem impurities & Crystalline ruaj khov

Qhov kev sib tw tseem ceeb hauv kev lag luam Baricitinib API yog tsis nyob rau hauv kev ua tiav purity, tab sis nyob rau hauv micro- kev tswj ntawm ib puag ncig synthesis. Ntawm Xi'an Tihealth, peb muab qhov tseem ceeb rauKev tswj hwm ntawm lub nplhaib Azetidinethiab kev hloov dua siab tshiab ntawm cov ntsiab lus tseem ceeb.

Peb pab neeg R&D tau txheeb xyuas tias thaum lub sijhawm de-kev tiv thaiv, kev tsim cov kab mob lactone impurities yog ib qho kev pheej hmoo tseem ceeb vim lawv cov polarity ze rau lub ntsiab compound. Los ntawm kev sivQuality by Design (QbD)cov hauv paus ntsiab lus-ua kom meej meej tswj cov tshuaj tiv thaiv pH nyob rau hauv qhov nqaim nruab nrab (7.0-7.5) thiab siv cov dej ntws tsis tu ncua micro-cov tshuaj tiv thaiv-peb tsis tu ncua txo cov impurities rau hauv qab no0.05%. Tsis tas li ntawd, txhawm rau lav lub txee- lub neej ruaj khov, peb siv sijhawm tiag tiag -XRPD saib xyuaslos xyuas kom meej tias peb cov khoom siv tsis muaj dej tsis muaj dej nyob ruaj khov txawm tias nyob hauv cov xwm txheej ceev (40℃/ 75% RH) rau 24 lub hlis.

 

Clinical Evolution: Targeted Intervention Beyond Conventional Borderaries

Tus nqi pharmacological ntawm Baricitinib tam sim no hloov ntawm "kev tiv thaiv dav dav-mob" mus rau "kev hloov kho lub cev muaj zog." Nyob rau theem kev tshawb fawb, nws lub luag haujlwm raws li kev xaivJAK1/JAK2 modulatormuab lub qhov rais tshwj xeeb rau kev kho mob uas tsis muaj kev xav tau.

Cov ntaub ntawv kho mob tsis ntev los no, suav nrog -lub sijhawm ntev BRAVE-AA cov kev tshawb fawb, qhia tias Baricitinib qhov ua tau zoo hauv qhov hnyavAlopecia Areata Covyog tsav los ntawm nws cov kev cai ruaj khov ntawm covIFN -taw qhia txoj hauv kev hauv cov plaub hau follicle microenvironment. Nrog ib nrab - lub neej ntawm kwv yees li 12.5 teev, nws muab cov kws kho mob nrog lub qhov rais zoo tagnrho rau kev siv tshuaj titration. Tsis tas li ntawd, kev tshawb nrhiav tshiab hauvSystemic Lupus Erythematosus (SLE)qhia tias molecule lub peev xwm los txo kev sib koom tes thiab kev koom tes ntawm daim tawv nqaij ua rau txoj hauv kev rau yav tom ntej tshwj xeeb kev xa khoom, xws li kev txhawb nqa - tso tawm lossis cov tshuaj pleev ib ce.

Vim li cas Xi'an Tihealth yog tus khub ntawm Kev Xaiv rau Baricitinib API

Raws li lub ntiaj teb cov thawj coj hauv kev faib khoom raw khoom txij li xyoo 2008, ua haujlwm tshaj 1,500 tus neeg siv khoom, Xi'an Tihealth muaj ntau tshaj li cov khoom lag luam; peb muab ibkev ua raws li- kev sib koom ua ke:

Analytical qhov tob:Txhua batch raug txheeb xyuas los ntawmH-NMR, LC-MS, thiab HPLC, kom ntseeg tau tias "lub nra ntawm impurity" yog qhov tsawg kawg nkaus rau kev ntseeg tau ntawm kev kho mob.

Regulatory Alignment:Peb cov khoom nruj me ntsis ua raws liISO 9001: 2015thiabICH Q3Acov txheej txheem, ua kom yooj yim rau kev sau npe thiab kev tshuaj xyuas cov txheej txheem rau cov chaw tsim tshuaj.

Scalable Logistics:Los ntawm mg- ntsuas ntsuas ntsuas mus rau MT- nplai kev lag luam batch, peb ua kom muaj kev ruaj khov, tshawb xyuas- npaj cov khoom xa tuaj.

Yav Tom Ntej Outlook: Kev Sib Nrauj ntawm AI thiab Green Synthesis

Lub neej yav tom ntej ntawm Baricitinib ntau lawm nyob rau hauv sustainability thiab efficiency.Xi'an Tihealthyog nquag nqis peev hauvenzymatic catalysisthiab AI- tau tsav txoj hauv kev ua kom zoo kom txo tau cov hneev taw ib puag ncig thaum tuav cov qauv purity siab tshaj. Raws li kev tiv thaiv kab mob txuas ntxiv mus rau ntau haiv neeg, Baricitinib tseem yog ib qho khoom muaj nqis tseem ceeb hauv lub ntiaj teb pharmacopeia.

Cov ntaub ntawv

Eli Lilly & Incyte (Cov Ntaub Ntawv Keeb Kwm): Clinical pharmacology thiab kev nyab xeeb profiles ntawm Olumiant.
https://www.olumiant.com/

PubChem Database (NIH): Cov ntaub ntawv tsim qauv thiab kev ua haujlwm lom neeg rau Baricitinib (CID: 44205240).
https://pubchem.ncbi.nlm.nih.gov/compound/Baricitinib

FDA Center for Drug Evaluation: Cov ntawv ceeb toom pom zoo thiab cov lus qhia luv luv rau JAK inhibitors.
https://www.accessdata.fda.gov/

ClinicalTrials.gov: Cov xwm txheej tam sim no ntawm Baricitinib sim hauv SLE thiab Alopecia Areata.
https://clinicaltrials.gov/

ICH Cov Lus Qhia Zoo: Cov qauv rau impurities hauv cov tshuaj tshiab (Q3A).
https://www.ich.org/page/quality{2}}cov lus qhia

Xa kev nug